Menarini Silicon Biosystems

📢 𝗪𝗲'𝗹𝗹 𝗯𝗲 𝗮𝘁 𝗔𝗔𝗖𝗥 𝟮𝟬𝟮𝟱! Our team is excited to attend the 𝗔𝗺𝗲𝗿𝗶𝗰𝗮𝗻 𝗔𝘀𝘀𝗼𝗰𝗶𝗮𝘁𝗶𝗼𝗻 𝗳𝗼𝗿 𝗖𝗮𝗻𝗰𝗲𝗿 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 (𝗔𝗔𝗖𝗥) 𝟮𝟬𝟮𝟱 𝗔𝗻𝗻𝘂𝗮𝗹 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 where the latest breakthroughs in cancer research take center stage. We look forward to connecting with you to share how our liquid solutions can empower your clinical trials, pairing circulating tumor cell testing with cfRNA/cfDNA analysis. 𝗦𝘁𝗼𝗽 𝗯𝘆 𝗯𝗼𝗼𝘁𝗵 #𝟮𝟬𝟱𝟳 to learn how we are Uncovering the Full Potential of Liquid Biopsy. See you there! #AACR25 #CancerResearch #LiquidBiopsy #LabServices

🌍 𝗖𝗲𝗹𝗲𝗯𝗿𝗮𝘁𝗶𝗻𝗴 𝗪𝗼𝗿𝗹𝗱 𝗛𝗲𝗮𝗹𝘁𝗵 𝗗𝗮𝘆! 🌍 At Menarini Silicon Biosystems, we recognize that advancing healthcare starts with innovation, collaboration, and a commitment to improving patient outcomes. On this 𝗪𝗼𝗿𝗹𝗱 𝗛𝗲𝗮𝗹𝘁𝗵 𝗗𝗮𝘆, we celebrate the scientists, physicians, and healthcare professionals working tirelessly to push the boundaries of medicine. Let’s continue working together to make quality healthcare accessible for all. #WorldHealthDay 

📢 Join us in Denver at the 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆 𝗡𝘂𝗿𝘀𝗶𝗻𝗴 𝗦𝗼𝗰𝗶𝗲𝘁𝘆 (𝗢𝗡𝗦) 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 April 9-13! Stop by 𝗯𝗼𝗼𝘁𝗵 # 𝟯𝟬𝟭𝟲 to learn why regular assessment of HER2 status is important and how our CELLSEARCH® Circulating Tumor Cell test with HER2 biomarker characterization can help. We hope to see you there! #CTC #Liquidbiopsy #ONSCongress #OncologyNursing

𝗛𝗮𝗽𝗽𝘆 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗟𝗶𝗮𝗶𝘀𝗼𝗻 𝗗𝗮𝘆! 🔬 At 𝗠𝗲𝗻𝗮𝗿𝗶𝗻𝗶 𝗦𝗶𝗹𝗶𝗰𝗼𝗻 𝗕𝗶𝗼𝘀𝘆𝘀𝘁𝗲𝗺𝘀, we celebrate our dedicated 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗟𝗶𝗮𝗶𝘀𝗼𝗻𝘀 (𝗠𝗦𝗟𝘀) who bridge the gap between science and healthcare. Their expertise, commitment, and passion drive innovation, support healthcare professionals, and ultimately improve patient care. 𝗧𝗛𝗔𝗡𝗞 𝗬𝗢𝗨 for the impact you make every day! #MSLDay #MedicalScienceLiaison 

Just published in Clinical Cancer Research—the results of the PREDICT global pooled analysis. This study is the largest pooled analysis with globally collected individual patient data to evaluate the role of serial circulating tumor cell (CTC) enumeration for risk assessment and treatment monitoring in 4,436 patients with metastatic breast cancer (MBC). The findings demonstrated clinical validity and potential clinical utility of serial CTC assessments as a reliable, minimally invasive tool for early treatment monitoring and risk stratification—regardless of tumor subtype or treatment. https://lnkd.in/dKfdFBgb #liquidbiopsy #CTC #MBC #predict

Join us at ISMRC 2025 – The Premier Congress on Liquid Biopsy & Circulating Biomarkers! We are honored to be attending ISMRC 2025, 7 - 9 May, the International Symposium on Minimal Residual Cancer, where leading experts from around the world will gather to discuss the latest breakthroughs in liquid biopsy, circulating biomarkers, and precision oncology. Looking forward to seeing you there! https://lnkd.in/evfAFv3K #ISMRC2025 #LiquidBiopsy #CancerResearch #PrecisionMedicine #CirculatingBiomarkers

We are excited to offer our unconditional contribution to the ECM course, Focus on TOP, happening this week in Udine. This event features presentations from leading global experts in oncology and aims to address the fast-evolving landscape of breast cancer management. With the shift toward personalized treatment approaches, the symposium will explore cutting-edge advancements in targeted therapies and biomarker development—including circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), next-generation sequencing, and multi-omics. These innovations highlight the importance of collaborative, interdisciplinary efforts to translate complex tools into meaningful clinical outcomes. More information is available at https://lnkd.in/gYQs-w6E #BreastCancer #CTC #FocusOnTop #PrecisionOncology #Oncology #CancerResearch #LiquidBiopsy

Don't miss your opportunity to join the live webinar and Q&A with Massimo Cristofanilli, MD, FACP, Professor of Medicine at Weill Cornell Medicine on March 12th (7PM EST) where he will present "Evaluation of HER2 Status on Peripheral Blood with CellSearch". Register Now! https://lnkd.in/gf6XCNAv #ctc #Cellsearch #HER2 #breastcancer #webinar

Today, we proudly recognize the 𝗶𝗻𝗰𝗿𝗲𝗱𝗶𝗯𝗹𝗲 𝘄𝗼𝗺𝗲𝗻 who drive innovation, inspire change, and shape the future of life sciences. At 𝗠𝗲𝗻𝗮𝗿𝗶𝗻𝗶 𝗦𝗶𝗹𝗶𝗰𝗼𝗻 𝗕𝗶𝗼𝘀𝘆𝘀𝘁𝗲𝗺𝘀, we are committed to fostering a workplace where equality, inclusion, and empowerment thrive. We celebrate the achievements of women in STEM while continuing to support the next generation of female leaders in healthcare and biotechnology. Join us in honoring the contributions of women everywhere. 💜 𝗛𝗮𝗽𝗽𝘆 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗪𝗼𝗺𝗲𝗻’𝘀 𝗗𝗮𝘆! 💜 #IWD2025 #InternationalWomensDay #WomenInSTEM #WomenInScience #MenariniSiliconBiosystems

March is Colorectal Cancer Awareness Month. At Menarini Silicon Biosystems we are committed to supporting health care providers with innovative tools to help monitor cancer progression and inform treatment decisions and we recognize our patient advocacy partners #FightCRC and the #ColorectalCancerAlliance for all the work they do to empower patients with knowledge and support. Together, we can raise awareness, advance the science, and improve outcomes for colorectal cancer patients. #ColorectalCancerAwareness #CancerCare #FightCRC #colorectalcanceralliance #MenariniSiliconBiosystems